Demonstrates MS Analysis Technology, Recently Secured FDA 510(k) Clearance Introduces 'Neurophet AQUA AD,' a Total Solution for Alzheimer's Disease Treatment Prescription, at the AI Theater SEOUL,...

Consumer study "Managed Wi-Fi: MDU Resident Demand & Preferences" and Smart Spaces sessions examines demand for advanced access control DALLAS, Dec. 5, 2024 /PRNewswire/ -- New consumer research...

Murata will be attending CES 2025 January 7-10 in Las Vegas. The booth in the Vehicle Technology Pavilion (West Hall Booth #6500) will serve as a showcase for the products that enable innovation...

Halia Therapeutics, Inc. (Halia), a clinical-stage biopharmaceutical company at the forefront of developing innovative treatments for chronic inflammatory diseases, today announced that David J....

Press Release at: https://docs.google.com/document/d/1oov7UTKeD-OUoaFE7W28LR5uSBqoHqBt/edit?usp=sharing&ouid=108034730091211394530&rtpof=true&sd=true SWISSTECH AT CES 2025: Hall G Level 1 BOOTH #...

The DEMETHER trial, whose principal investigator is Dr. Javier Cortés, explores an innovative therapeutic de-escalation strategy for patients with previously untreated HER2-positive advanced...

MetaOptics Technologies Pte. Ltd. is excited to announce its participation at CES 2025, taking place in Las Vegas from January 7-10, 2025. MetaOptics will unveil its latest advancements in...

Longboard Pharmaceuticals, now a wholly owned subsidiary of Lundbeck, presents scientific data in multiple poster presentations showcasing the potential of bexicaserin in Developmental and...

-- Treatment with both combination regimens demonstrates synergistic anti-tumor activity, supporting planned combination strategy for EO-3021 in patients with gastric or gastroesophageal junction...

Pixelgen Technologies, a leader in cell surface proteomics for single cells, today announced upcoming participation at the 66th American Society of Hematology Annual Meeting and Exposition (ASH)...